Guidelines for biomarker testing in advanced non-small-cell lung cancer. A national consensus of the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP)
作者： Pilar Garrido , Javier de Castro , Ángel Concha , Enriqueta Felip , Dolores Isla
DOI: 10.1007/S12094-012-0806-2
关键词: Internal medicine 、 Biomarker (medicine) 、 KRAS 、 Biomarker Analysis 、 Pathology 、 Anaplastic lymphoma kinase 、 Oncology 、 Medicine 、 Clinical trial 、 Context (language use) 、 Lung cancer 、 Gene mutation
摘要: … mutations is currently regarded as a predictive factor for efficacy of treatment with EGFR … The histological classification of lung cancer was defined by the WHO in 1999, and updated …
unirioja.es
springer.com
sci-hub.se 
seom.org 参考文章(50)
Nappi O, Fontanini G, Crinò L, Aiom Siapec-Iap, Gambacorta M, Bardelli A, Normanno N, Comin C, Botti G, Ardizzoni A, Taddei Gl, Murer B, Marchetti A, Adamo, Pinto C, Recommendations for mutational analysis of EGFR in lung carcinoma. Pathologica. ,vol. 102, pp. 119- 126 ,(2010)
William D. Travis, Pathology and genetics of tumours of the lung , pleura, thymus and heart Published in <b>2004</b> in Lyon by IARC. ,(2004)
Bárbara Angulo, Elena García-García, Rebeca Martínez, Ana Suárez-Gauthier, Esther Conde, Manuel Hidalgo, Fernando López-Ríos, A Commercial Real-Time PCR Kit Provides Greater Sensitivity than Direct Sequencing to Detect KRAS Mutations The Journal of Molecular Diagnostics. ,vol. 12, pp. 292- 299 ,(2010) , 10.2353/JMOLDX.2010.090139
Shahreen Billah, John Stewart, Gregg Staerkel, Su Chen, Yun Gong, Ming Guo, EGFR and KRAS mutations in lung carcinoma: Molecular testing by using cytology specimens Cancer Cytopathology. ,vol. 119, pp. 111- 117 ,(2011) , 10.1002/CNCY.20151
José Manuel Trigo Pérez, Pilar Garrido López, Enriqueta Felip Font, Dolores Isla Casado, SEOM clinical guidelines for the treatment of non-small-cell lung cancer: an updated edition Clinical and Translational Oncology. ,vol. 12, pp. 735- 741 ,(2010) , 10.1007/S12094-010-0588-3
William Travis, Natasha Rekhtman, Pathological diagnosis and classification of lung cancer in small biopsies and cytology: strategic management of tissue for molecular testing. Seminars in Respiratory and Critical Care Medicine. ,vol. 32, pp. 022- 031 ,(2011) , 10.1055/S-0031-1272866
William Pao, Marc Ladanyi, Epidermal growth factor receptor mutation testing in lung cancer: searching for the ideal method. Clinical Cancer Research. ,vol. 13, pp. 4954- 4955 ,(2007) , 10.1158/1078-0432.CCR-07-1387
Robert Pirker, Felix JF Herth, Keith M Kerr, Martin Filipits, Miquel Taron, David Gandara, Fred R Hirsch, Dominique Grunenwald, Helmut Popper, Egbert Smit, Manfred Dietel, Antonio Marchetti, Christian Manegold, Peter Schirmacher, Michael Thomas, Rafael Rosell, Federico Cappuzzo, Rolf Stahel, European EGFR Workshop Group, None, Consensus for EGFR Mutation Testing in Non-small Cell Lung Cancer: Results from a European Workshop Journal of Thoracic Oncology. ,vol. 5, pp. 1706- 1713 ,(2010) , 10.1097/JTO.0B013E3181F1C8DE
Marie Brevet, Maria Arcila, Marc Ladanyi, Assessment of EGFR Mutation Status in Lung Adenocarcinoma by Immunohistochemistry Using Antibodies Specific to the Two Major Forms of Mutant EGFR The Journal of Molecular Diagnostics. ,vol. 12, pp. 169- 176 ,(2010) , 10.2353/JMOLDX.2010.090140
Qiulu Pan, William Pao, Marc Ladanyi, Rapid Polymerase Chain Reaction-Based Detection of Epidermal Growth Factor Receptor Gene Mutations in Lung Adenocarcinomas The Journal of Molecular Diagnostics. ,vol. 7, pp. 396- 403 ,(2005) , 10.1016/S1525-1578(10)60569-7